SCHEMBL5504169

SCHEMBL5504169

COCONC1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.42
ALDH1A1 P00352 2/20 0.36
HSD17B10 Q99714 1/20 0.36
EPHX2 P34913 4/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
EPHX1 P07099 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27425116 0.80 EPHX2 (0.42) NPSR1ALDH1A1HSD17B10EPHX2LMNA
SCHEMBL23096811 0.78 THRB (0.35) NPSR1ALDH1A1HSD17B10LMNAKDM4E
SCHEMBL3780791 0.78 KCNH2 (0.36) EPHX1
SCHEMBL6062101 0.76 ALDH1A1 (0.39) NPSR1ALDH1A1HSD17B10LMNAKDM4E
SCHEMBL18629040 0.73 EPHX1 (0.40) NPSR1ALDH1A1HSD17B10SMN1; SMN2KDM4E
SCHEMBL31035976 0.73 CYP1A2 (0.41) NPSR1ALDH1A1HSD17B10EPHX2KDM4E
SCHEMBL16135444 0.73 CYP1A2 (0.41) NPSR1ALDH1A1HSD17B10EPHX2KDM4E
SCHEMBL21958303 0.72 ALDH1A1 (0.45) NPSR1ALDH1A1HSD17B10EPHX2SMN1; SMN2
SCHEMBL21567116 0.72 ALDH1A1 (0.45) NPSR1ALDH1A1HSD17B10EPHX2SMN1; SMN2
SCHEMBL21958304 0.72 ALDH1A1 (0.45) NPSR1ALDH1A1HSD17B10EPHX2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1846395-A1 PYRAZOLE DERIVATIVES FOR THE INHIBITION OF CDK'S AND GSK'S Astex Therapeutics Limited (GB) 2007-10-24 EP disclosed
WO-2006077414-A1 PYRAZOLE DERIVATIVES FOR THE INHIBITION OF CDK' S AND GSK' S ASTEX THERAPEUTICS LIMITED (GB) 2006-07-27 WO disclosed